Newborn screening enables the doctor to see the condition affecting a child’s long-term health or survival. Early detection, diagnosis, and intervention will prevent death or disability and enable kids to reach their full potential. In US, lots of babies each year are monitored routinely, utilizing few drops of blood from the newborn’s heel, for certain genetic, endocrine, and metabolic disorders, and are also tested for hearing loss and critical congenital heart defects (CCHDs) before discharge from a hospital or birth center.
Newborn screening equipment market is expected to be around US$ 785 Million by 2028 at a CAGR of 12.12% over the forecast years.
Further, the launch of improved performance instruments of mass spectroscopy and oximeters is additionally expected to help market growth. As an example, PerkinElmer’s TDQ screening system utilizes tandem quadrupole analysis that provides the regular sturdy screening along with higher sensitivity and quicker scanning. Rising prevalence of congenital disorders is also likely to boost market growth over the forecast period.
Market Insights
The global Newborn Screening Equipment market is segregated on the basis of Application as Hospitals, Clinics, Local health departments, Government agencies, International organizations, and Community organizations. Based on Type the global Newborn Screening Equipment market is segmented in Phenylketonuria (PKU), Sickle cell disease, MCAD deficiency, Tyrosinemia, and Others.
The global Newborn Screening Equipment market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Newborn Screening Equipment market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Agilent Technologies Inc., Natus Medical Inc., Covidien Plc, Trivitron Healthcare, GE Healthcare, Masimo Corp., AB Sciex LLC, Waters Corp., PerkinElmer Inc, Bio-Rad Laboratories Inc., and others are among the major players in the global Newborn Screening Equipment market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Newborn Screening Equipment Market has been segmented as below:
Newborn Screening Equipment Market, By Application
Newborn Screening Equipment Market, By Type
Newborn Screening Equipment Market, By Region
Newborn Screening Equipment Market, By Company
The report covers:
Report Scope:
The global Newborn Screening Equipment market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Newborn Screening Equipment market share. Major industry players with significant revenue share include Agilent Technologies Inc., Natus Medical Inc., Covidien Plc, Trivitron Healthcare, GE Healthcare, Masimo Corp., AB Sciex LLC, Waters Corp., PerkinElmer Inc, Bio-Rad Laboratories Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Newborn Screening Equipment Market, By Application
5.1 Introduction
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Clinics
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Local health departments
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Government agencies
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 International organizations
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Community organizations
5.7.1 Market Overview
5.7.2 Market Size and Forecast
6. Newborn Screening Equipment Market, By Type
6.1 Introduction
6.2 Phenylketonuria (PKU)
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Sickle cell disease
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 MCAD deficiency
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Tyrosinemia
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Others
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Newborn Screening Equipment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Newborn Screening Equipment, By Application
7.2.2 North America Newborn Screening Equipment, By Type
7.3 Europe
7.3.1 Europe Newborn Screening Equipment, By Application
7.3.2 Europe Newborn Screening Equipment, By Type
7.4 Asia-Pacific
7.4.1 Asia-Pacific Newborn Screening Equipment, By Application
7.4.2 Asia-Pacific Newborn Screening Equipment, By Type
7.5 Rest of the World
7.5.1 Rest of the World Newborn Screening Equipment, By Application
7.5.2 Rest of the World Newborn Screening Equipment, By Type
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Agilent Technologies Inc.
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Natus Medical Inc.
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Covidien Plc
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Trivitron Healthcare
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 GE Healthcare
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Masimo Corp.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 AB Sciex LLC
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Waters Corp.
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 PerkinElmer Inc
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Bio-Rad Laboratories Inc.
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Newborn Screening Equipment Market has been segmented as below:
Newborn Screening Equipment Market, By Application
Newborn Screening Equipment Market, By Type
Newborn Screening Equipment Market, By Region
Newborn Screening Equipment Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
